Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9HBH5
UPID:
RDH14_HUMAN
Alternative names:
Alcohol dehydrogenase PAN2; Short chain dehydrogenase/reductase family 7C member 4
Alternative UPACC:
Q9HBH5
Background:
Retinol dehydrogenase 14 (RDH14), also known as Alcohol dehydrogenase PAN2 and Short chain dehydrogenase/reductase family 7C member 4, is a pivotal enzyme in retinol metabolism. It exhibits a strong preference for NADP and is highly active towards various forms of retinol, including 9-cis, 11-cis, and all-trans-retinol, while demonstrating minimal activity towards 13-cis-retinol. RDH14 does not engage in steroid metabolism.
Therapeutic significance:
Understanding the role of Retinol dehydrogenase 14 could open doors to potential therapeutic strategies.